Cheng Zhen

机构：Tongji University, National Medical Products Administration, Sichuan University, Chinese PLA General Hospital, National Clinical Research Center for Digestive Diseases, Shanghai Tenth People's Hospital, ZheJiang Institute For Food and Drug Control, Phoenix Contact (United States) · ORCID：0000-0003-2396-1261

发表论文 84 篇 · 总被引 1319 次 · h-index 21

代表论文

• Otilonium Bromide Exhibits Potent Antifungal Effects by Blocking Ergosterol Plasma Membrane Localization and Triggering Cytotoxic Autophagy in Candida Albicans (2024 · Advanced Science · 被引 15)
• Geldanamycin confers fungicidal properties to azole by triggering the activation of succinate dehydrogenase (2024 · Life Sciences · 被引 13)
• Prevalence of Myopia and Axial Length Distribution in China: The Wuhu Children and Adolescents Eye Study (2025 · Investigative Ophthalmology & Visual Science · 被引 11)
• Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial (2025 · Stem Cell Research & Therapy · 被引 10)
• Landscape of gut mucosal immune cells showed gap of follicular or memory B cells into plasma cells in immunological non‐responders (2024 · Clinical and Translational Medicine · 被引 8)
• FRI-292 Single-cell immune profiling of liver and blood reveals pretreatment signatures associated with treatment outcomes in young children with chronic hepatitis B (2025 · Journal of Hepatology · 被引 6)